NCT00427934 - Maraviroc in Rheumatoid Arthritis | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

Maraviroc

300 mg (2- 150 mg tablets) are administered by mouth twice a day (BID) for 12 weeks.

DRUG

Maraviroc Placebo

Placebo tablets to match active drug. Two tablets are administered by mouth twice a day (BID) for 12 weeks.

Trial Locations (44)

4558

Pfizer Investigational Site, Maroochydore

5011

Pfizer Investigational Site, Woodville

7001

Pfizer Investigational Site, Hobart

10117

Pfizer Investigational Site, Berlin

13210

Pfizer Investigational Site, Syracuse

14059

Pfizer Investigational Site, Berlin

15705

Pfizer Investigational Site, Santiago de Compostela

16132

Pfizer Investigational Site, Genova

16635

Pfizer Investigational Site, Duncansville

27100

Pfizer Investigational Site, Pavia

28007

Pfizer Investigational Site, Madrid

28601

Pfizer Investigational Site, Hickory

28602

Pfizer Investigational Site, Hickory

31405

Pfizer Investigational Site, Savannah

31406

Pfizer Investigational Site, Savannah

32114

Pfizer Investigational Site, Daytona Beach

32127

Pfizer Investigational Site, Port Orange

41014

Pfizer Investigational Site, Seville

42431

Pfizer Investigational Site, Madisonville

44690

Pfizer Investigational Site, Guadalajara

49005

Pfizer Investigational Site, Dnipropetrovsk

49007

Pfizer Investigational Site, Kalamazoo

49048

Pfizer Investigational Site, Kalamazoo

58701

Pfizer Investigational Site, Minot

61000

Pfizer Investigational Site, Kharkiv

61265

Pfizer Investigational Site, Moline

68154

Pfizer Investigational Site, Omaha

89128

Pfizer Investigational Site, Las Vegas

92646

Pfizer Investigational Site, Huntington Beach

94115

Pfizer Investigational Site, San Francisco

95017

Pfizer Investigational Site, Simferopol

560003

Pfizer Investigational Site, Bangalore

06518

Pfizer Investigational Site, Hamden

06450

Pfizer Investigational Site, Meriden

06510-2716

Pfizer Investigational Site, New Haven

06511-5473

Pfizer Investigational Site, New Haven

04103

Pfizer Investigational Site, Leipzig

500 082

Pfizer Investigational Site, Hyderabad

560 034

Pfizer Investigational Site, Bangalore

CP 44340

Pfizer Investigational Site, Guadalajara

3000-075

Pfizer Investigational Site, Coimbra

1000-247

Pfizer Investigational Site, Lisbon

1600-035

Pfizer Investigational Site, Lisbon

08035

Pfizer Investigational Site, Barcelona